MoneyWorks4Me

Cadila Healthcare informs about company updates

06 Dec 2019 Evaluate

Cadila Healthcare has informed about inspection by USFDA of the company’s API manufacturing facility located at Dabhasa, Gujarat and company received an Establishment Inspection Report (EIR) which stated that the classification of the facility is ‘No Action Indicated (NAI)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..